Document:

Exhibit 10.6

 

PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT

 

THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT, dated as of [•],
2021 (as it may from time to time be amended and including all exhibits referenced herein, this “Agreement”), is entered
into by and between USA Acquisition Corp., a Delaware corporation (the “Company”), and USA Sponsor Acquisition LLC,
a Delaware limited liability company (the “Purchaser”).

 

WHEREAS, the Company intends to consummate an initial public offering
of the Company’s units (the “Public Offering”), each unit consisting of one share of the Company’s Class A
common stock, par value $0.0001 per share (each, a “Share”), and one-half of one redeemable warrant. Each whole warrant
entitles the holder to purchase one Share at an exercise price of $11.50 per Share. The Purchaser has agreed to purchase an aggregate
of 6,647,500 warrants (or up to 7,395,625 warrants in the aggregate to the extent the over-allotment option in connection with the Public
Offering is exercised in full) (the “Private Placement Warrants”), each Private Placement Warrant entitling the holder
to purchase one Share at an exercise price of $11.50 per Share.

 

NOW THEREFORE, in consideration of the mutual promises contained in
this Agreement and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties to
this Agreement hereby, intending legally to be bound, agree as follows:

 

AGREEMENT

 

Section 1 Authorization, Purchase and Sale; Terms of the Private
Placement Warrants.

 

A. Authorization of the Private Placement Warrants. The Company
has duly authorized the issuance and sale of the Private Placement Warrants, and, subject to the proper exercise of the Private Placement
Warrants and against payment therefor, the Shares underlying such Private Placement Warrants, to the Purchaser.

 

B. Purchase and Sale of the Private Placement Warrants. On the
date of the consummation of the Public Offering or on such earlier time and date as may be mutually agreed by the Purchaser and the Company
(the “Initial Closing Date”), the Company shall issue and sell to the Purchaser, and the Purchaser shall purchase from
the Company, an aggregate of 6,647,500 Private Placement Warrants at a price of $1.00 per warrant for an aggregate purchase price of $6,647,500
(the “Purchase Price”), which shall be paid by wire transfer of immediately available funds to the Company in accordance
with the Company’s wiring instructions at least one business day prior to the Initial Closing Date, including to the trust account
(the “Trust Account”), at a financial institution to be chosen by the Company, maintained by Continental Stock Transfer &
Trust Company, acting as trustee. On the Initial Closing Date, subject to receipt of funds pursuant to the immediately prior sentence,
the Company shall either, at its option, deliver certificates evidencing the Private Placement Warrants purchased by the Purchaser on
such date duly registered in the Purchaser’s name to the Purchaser, or effect such delivery in book-entry form.

 

On the date of any closing of the over-allotment option in connection
with the Public Offering or on such earlier time and date as may be mutually agreed by the Purchaser and the Company (each such date,
an “Over-allotment Closing Date,” and each Over-allotment Closing Date (if any) and the Initial Closing Date being
sometimes referred to herein as a “Closing Date”), the Company shall issue and sell to the Purchaser, and the Purchaser
shall purchase from the Company, up to an aggregate of 748,125 Private Placement Warrants, in the same proportion as the amount of the
over-allotment option that is exercised, at a price of $1.00 per warrant for an aggregate purchase price of up to $748,125 (if the over-allotment
option in connection with the Public Offering is exercised in full) (the “Over-allotment Purchase Price”), which shall
be paid by wire transfer of immediately available funds to the Company in accordance with the Company’s wiring instructions at least
one business day prior to each Over-allotment Closing Date. On the Over-allotment Closing Date, upon the payment by the Purchaser of the
Over-allotment Purchase Price by wire transfer of immediately available funds to the Company, the Company shall either, at its option,
deliver certificates evidencing the Private Placement Warrants purchased by the Purchaser on such date duly registered in the Purchaser’s
name to the Purchaser, or effect such delivery in book-entry form.

 

     

     

    

 

C. Terms of the Private Placement Warrants.

 

(i) The Private Placement Warrants shall have their terms set
forth in a Warrant Agreement to be entered into by the Company and a warrant agent, in connection with the Public Offering (a “Warrant
Agreement”).

 

(ii) At or prior to the time of the Initial Closing Date, the
Company and the Purchaser shall enter into a registration rights agreement (the “Registration Rights Agreement”) pursuant
to which the Company will grant certain registration rights to the Purchaser relating to the Private Placement Warrants and the Shares
underlying the Private Placement Warrants.

 

Section 2
Representations and Warranties of the Company. As a material inducement to the Purchaser to enter into this Agreement and purchase
the Private Placement Warrants, the Company hereby represents and warrants to the Purchaser (which representations and warranties shall
survive each Closing Date) that:

 

A. Organization and Corporate Power. The Company is a corporation
duly organized, validly existing and in good standing under the laws of the State of Delaware and is qualified to do business in every
jurisdiction in which the failure to so qualify would reasonably be expected to have a material adverse effect on the financial condition,
operating results or assets of the Company. The Company possesses all requisite corporate power and authority necessary to carry out the
transactions contemplated by this Agreement and the Warrant Agreement.

 

B. Authorization; No Breach.

 

(i) The execution, delivery and performance of this Agreement
and the Private Placement Warrants, and, subject to proper exercise of the Private Placement Warrants and against payment therefor, the
Shares underlying such Private Placement Warrants, have been duly authorized and approved by the Company as of each Closing Date. This
Agreement constitutes a valid and binding obligation of the Company, enforceable in accordance with its terms, subject to bankruptcy,
insolvency, fraudulent conveyance, reorganization, moratorium and other laws of general applicability relating to or affecting creditors’
rights and to general equitable principles (whether considered in a proceeding in equity or law). Upon each issuance of Private Placement
Warrants in accordance with, and payment pursuant to, the terms of the Warrant Agreement and this Agreement, the Private Placement Warrants
will constitute valid and binding obligations of the Company, enforceable in accordance with their terms.

 

(ii) The execution and delivery by the Company of this Agreement
and the Private Placement Warrants, the issuance and sale of the Private Placement Warrants, the issuance of the Shares upon exercise
of the Private Placement Warrants and the fulfillment of, and compliance with, the respective terms hereof and thereof by the Company,
do not and will not as of each Closing Date (a) conflict with or result in a breach of the terms, conditions or provisions of, (b) constitute
a default under, (c) result in the creation of any lien, security interest, charge or encumbrance upon the Company’s capital
stock or assets under, (d) result in a violation of, or (e) require any authorization, consent, approval, exemption, action,
notice, declaration or filing, in each case, by or to any court or administrative or governmental body or agency pursuant to the amended
and restated certificate of incorporation or the bylaws of the Company (in effect on the date hereof or as may be amended prior to completion
of the contemplated Public Offering), or any material law, statute, rule or regulation to which the Company is subject, or any agreement,
order, judgment or decree to which the Company is subject, except for any filings required after the date hereof under federal or state
securities laws.

 

C. Title to Securities. Upon issuance in
accordance with, and payment pursuant to, the terms hereof and the Warrant Agreement, the Private Placement Warrants will be duly
and validly issued and the Shares issuable upon exercise of the Private Placement Warrants will be duly and validly issued, fully
paid and nonassessable. On the date of issuance of the Private Placement Warrants, the Shares issuable upon exercise of the Private
Placement Warrants shall have been reserved for issuance. Upon issuance in accordance with, and payment pursuant to, the terms
hereof and the Warrant Agreement, the Purchaser will have good title to the Private Placement Warrants and the Shares issuable upon
exercise of such Private Placement Warrants, free and clear of all liens, claims and encumbrances of any kind, other than
(i) transfer restrictions hereunder and under the other agreements contemplated hereby, (ii) transfer restrictions under
federal and state securities laws, and (iii) liens, claims or encumbrances imposed due to the actions of the Purchaser.

 

     

     

    

 

D. Governmental Consents. No permit, consent, approval or
authorization of, or declaration to or filing with, any governmental authority is required in connection with the execution,
delivery and performance by the Company of this Agreement or the consummation by the Company of any other transactions contemplated
hereby, except for applicable requirements of the Securities Act.

 

Section 3
Representations and Warranties of the Purchaser. As a material inducement to the Company to enter into this Agreement and issue
and sell the Private Placement Warrants to the Purchaser, the Purchaser hereby represents and warrants to the Company (which representations
and warranties shall survive each Closing Date) that:

 

A. Organization and Requisite Authority. The Purchaser possesses
all requisite power and authority necessary to carry out the transactions contemplated by this Agreement.

 

B. Authorization; No Breach.

 

(i) This Agreement constitutes a valid and binding obligation
of the Purchaser, enforceable in accordance with its terms, subject to bankruptcy, insolvency, fraudulent conveyance, reorganization,
moratorium and other laws of general applicability relating to or affecting creditors’ rights and to general equitable principles
(whether considered in a proceeding in equity or law).

 

(ii) The execution and delivery by the Purchaser of this Agreement
and the fulfillment of and compliance with the terms hereof by the Purchaser does not and shall not as of each Closing Date conflict with
or result in a breach by the Purchaser of the terms, conditions or provisions of any agreement, instrument, order, judgment or decree
to which the Purchaser is subject that would materially impact its ability to perform its obligations hereunder.

 

C. Investment Representations.

 

(i) The Purchaser is acquiring the Private Placement Warrants
and, upon exercise of the Private Placement Warrants, the Shares issuable upon such exercise (collectively, the “Securities”),
for the Purchaser’s own account, for investment purposes only and not with a view towards, or for resale in connection with, any
public sale or distribution thereof.

 

(ii) The Purchaser is an “accredited investor” as
such term is defined in Rule 501(a)(3) of Regulation D under the Securities Act of 1933, as amended (the “Securities
Act”), and the Purchaser has not experienced a disqualifying event as enumerated pursuant to Rule 506(d) of Regulation
D under the Securities Act.

 

(iii) The Purchaser understands that the Securities are being
offered and will be sold to it in reliance on specific exemptions from the registration requirements of the United States federal and
state securities laws and that the Company is relying upon the truth and accuracy of, and the Purchaser’s compliance with, the representations
and warranties of the Purchaser set forth herein in order to determine the availability of such exemptions and the eligibility of the
Purchaser to acquire such Securities.

 

(iv) The Purchaser did not decide to enter into this Agreement
as a result of any general solicitation or general advertising within the meaning of Rule 502(c) of Regulation D under the Securities
Act.

 

(v) The Purchaser has been furnished with all materials relating
to the business, finances and operations of the Company and materials relating to the offer and sale of the Securities which have been
requested by the Purchaser. The Purchaser has been afforded the opportunity to ask questions of the executive officers and directors of
the Company. The Purchaser understands that its investment in the Securities involves a high degree of risk and it has sought such accounting,
legal and tax advice as it has considered necessary to make an informed investment decision with respect to the acquisition of the Securities.

 

(vi) The Purchaser understands that no United States federal or
state agency or any other government or governmental agency has passed on or made any recommendation or endorsement of the Securities
or the fairness or suitability of the investment in the Securities by the Purchaser nor have such authorities passed upon or endorsed
the merits of the offering of the Securities.

 

     

     

    

 

(vii) The Purchaser understands that: (a) the
Securities have not been and are not being registered under the Securities Act or any state securities laws, and may not be offered
for sale, sold, assigned or transferred unless (1) subsequently registered thereunder or (2) sold in reliance on an
exemption therefrom; and (b) except as specifically set forth in the Registration Rights Agreement, neither the Company nor any
other person is under any obligation to register the Securities under the Securities Act or any state securities laws or to comply
with the terms and conditions of any exemption thereunder. While the Purchaser understands that Rule 144 under the Securities
Act is not available for the resale of securities initially issued by shell companies (other than business combination related shell
companies) or issuers that have been at any time previously a shell company, the Purchaser understands that Rule 144 includes
an exception to this prohibition if the following conditions are met: (i) the issuer of the securities that was formerly a
shell company has ceased to be a shell company; (ii) the issuer of the securities is subject to the reporting requirements of
Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”);
(iii) the issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable, during
the preceding 12 months (or such shorter period that the issuer was required to file such reports and materials), other than
Form 8-K reports; and (iv) at least one year has elapsed from the time that the issuer filed current Form 10 type
information with the U.S. Securities and Exchange Commission (the “SEC”) reflecting its status as an entity that
is not a shell company.

 

(viii) The Purchaser has knowledge and experience in financial
and business matters, understands the high degree of risk associated with investments in the securities of companies in the development
stage such as the Company, is capable of evaluating the merits and risks of an investment in the Securities and is able to bear the economic
risk of an investment in the Securities in the amount contemplated hereunder for an indefinite period of time. The Purchaser has adequate
means of providing for its current financial needs and contingencies and will have no current or anticipated future needs for liquidity
which would be jeopardized by the investment in the Securities. The Purchaser can afford a complete loss of its investment in the Securities.

 

(ix) The Purchaser understands that the Private Placement Warrants
shall bear the legend substantially in the form set forth in the Warrant Agreement and be subject to appropriate “stop transfer
restrictions.”

 

Section 4
Conditions of the Purchaser’s Obligations. The obligations of the Purchaser to purchase and pay for the Private Placement
Warrants are subject to the fulfillment, on or before each Closing Date, of each of the following conditions:

 

A. Representations and Warranties. The representations and warranties
of the Company contained in Section 2 hereof shall be true and correct at and as of such Closing Date as though then made.

 

B. Performance. The Company shall have performed and complied
with all agreements, obligations and conditions contained in this Agreement that are required to be performed or complied with by it on
or before such Closing Date.

 

C. No Injunction. No litigation, statute, rule, regulation,
executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by or in any court or governmental
authority of competent jurisdiction or any self-regulatory organization having authority over the matters contemplated hereby, which prohibits
the consummation of any of the transactions contemplated by this Agreement or the Warrant Agreement.

 

D. Warrant Agreement and Registration Rights Agreement. The
Company shall have entered into the Warrant Agreement and the Registration Rights Agreement, each on terms satisfactory to the Purchaser.

 

E. Corporate Consents. The Company shall have obtained the consent
of its Board of Directors authorizing the execution, delivery and performance of this Agreement and the Warrant Agreement and the issuance
and sale of the Private Placement Warrants hereunder.

 

Section 5 Conditions of the Company’s Obligations. The
obligations of the Company to the Purchaser under this Agreement are subject to the fulfillment, on or before each Closing Date, of each
of the following conditions:

 

A. Representations and Warranties. The representations and warranties
of the Purchaser contained in Section 3 hereof shall be true and correct at and as of such Closing Date as though then made.

 

B. Performance. The Purchaser shall have performed and complied
with all agreements, obligations and conditions contained in this Agreement that are required to be performed or complied with by the
Purchaser on or before such Closing Date.

 

     

     

    

 

C. Corporate Consents. The Company shall have obtained the consent
of its Board of Directors authorizing the execution, delivery and performance of this Agreement and the Warrant Agreement and the issuance
and sale of the Private Placement Warrants hereunder.

 

D. No Injunction. No litigation, statute, rule, regulation,
executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by or in any court or governmental
authority of competent jurisdiction or any self-regulatory organization having authority over the matters contemplated hereby, which prohibits
the consummation of any of the transactions contemplated by this Agreement or the Warrant Agreement.

 

E. Warrant Agreement. The Company shall have entered into the
Warrant Agreement on terms satisfactory to the Company.

 

Section 6
Termination. This Agreement may be terminated at any time after December 31, 2021 upon the election by either the Company
or the Purchaser upon written notice to the other party if the closing of the Public Offering does not occur prior to such date.

 

Section 7
Survival of Representations and Warranties. All of the representations and warranties contained herein shall survive each Closing
Date.

 

Section 8
Definitions. Terms used but not otherwise defined in this Agreement shall have the meaning assigned to such terms in the registration
statement on Form S-1 the Company has filed with the SEC under the Securities Act.

 

Section 9 Miscellaneous.

 

A. Successors and Assigns. Except as otherwise expressly provided
herein, all covenants and agreements contained in this Agreement by or on behalf of any of the parties hereto shall bind and inure to
the benefit of the respective successors of the parties hereto whether so expressed or not. Notwithstanding the foregoing or anything
to the contrary herein, the parties may not assign this Agreement without the prior written consent of the other party hereto, other than
assignments by the Purchaser to its affiliates (including, without limitation, one or more of its members, as applicable).

 

B. Severability. Whenever possible, each provision of this Agreement
shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement is held
to be prohibited by or invalid under applicable law, such provision shall be ineffective only to the extent of such prohibition or invalidity,
without invalidating the remainder of this Agreement.

 

C. Counterparts. This Agreement may be executed simultaneously
in two or more counterparts, none of which need contain the signatures of more than one party, but all such counterparts taken together
shall constitute one and the same agreement. In the event that any signature is delivered by facsimile transmission or by e-mail delivery
of a “pdf” format data file, such signature shall create a valid and binding obligation of the party executing (or on whose
behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf” signature page were
an original thereof.

 

D. Descriptive Headings; Interpretation. The descriptive headings
of this Agreement are inserted for convenience only and do not constitute a substantive part of this Agreement. The use of the word “including”
in this Agreement shall be by way of example rather than by limitation.

 

E. Governing Law. This Agreement shall be deemed to be a contract
made under the laws of the State of New York and for all purposes shall be construed in accordance with the internal laws of the State
of New York.

 

F. Amendments. This Agreement may not be amended, modified or
waived as to any particular provision, except by a written instrument executed by all parties hereto.

 

[Signature Page Follows]

 

     

     

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Agreement to be effective as of the date first set forth above.

 

	 	COMPANY:
	 	 
	 	USA ACQUISITION CORP.,

a Delaware corporation
	 	 	 
	 	By:  	 
	 	 	Name:	Edward R. Smith
	 	 	Title:	Chief Executive Officer
	 	 
	 	PURCHASER:
	 	 
	 	
    USA SPONSOR ACQUISITION LLC,

    a Delaware limited liability company

	 	 	 
	 	By:	 
	 	 	Name:  	Edward R. Smith
	 	 	Title:	Authorized Signatory

 

[Signature
Page to Private Placement Warrants Purchase Agreement]Exhibit 10.8

 

THE SECURITIES DESCRIBED HEREIN HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933 OR THE SECURITIES LAWS OF ANY STATE OR ANY OTHER JURISDICTION. THERE ARE FURTHER RESTRICTIONS
ON THE TRANSFERABILITY OF THE SECURITIES DESCRIBED HEREIN.

 

THE PURCHASE OF THE SECURITIES INVOLVES A HIGH
DEGREE OF RISK AND SHOULD BE CONSIDERED ONLY BY PERSONS WHO CAN BEAR THE RISK OF THE LOSS OF THEIR ENTIRE INVESTMENT.

 

SUBSCRIPTION AGREEMENT

 

This Subscription Agreement
(this “Agreement”) is entered into as of [_______], 2021, by and among USA Acquisition Corp., a Delaware corporation
(the “Company”), USA Sponsor Acquisition LLC, a Delaware limited liability company (the “Sponsor”),
and [APOLLO ENTITY] (the “Purchaser”).

 

RECITALS

 

WHEREAS, the Company was incorporated
for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination
involving the Company and one or more businesses (a “Business Combination”);

 

WHEREAS, the Company has filed
with the U.S. Securities and Exchange Commission (the “Commission”) a registration statement on Form S-1 (the
 “Registration Statement”) for its initial public offering (“IPO”) of units (the “Public
Units”), at a price of $10.00 per Public Unit, each Public Unit comprised of one share of the Company’s Class A common
stock, par value $0.0001 per share (“Class A Common Stock”, and the shares of Class A Common Stock included
in the Public Units, the “Public Shares”), and one-half of one redeemable warrant, where each whole warrant entitles
the holder thereof to purchase one share of Class A Common Stock at a price of $11.50 per share, subject to adjustments as described
in the Registration Statement and the accompanying prospectus (the “Warrants”, and the Warrants included in the Public
Units, the “Public Warrants”);

 

WHEREAS, proceeds from the
IPO and the sale of the Private Placement Warrants (as defined below) in an aggregate amount equal to the aggregate gross proceeds from
the IPO will be deposited into a trust account for the benefit of the holders of the Public Shares (the “Trust Account”),
as described in the Registration Statement;

 

WHEREAS, following the closing
of the IPO (the “IPO Closing”), the Company will seek to identify and consummate a Business Combination;

 

WHEREAS, in connection with
the IPO, the Sponsor and the Purchaser will purchase, in a private placement that will close simultaneously with the IPO Closing, private
placement warrants (the “Private Placement Warrants”) for a purchase price of $1.00 per Private Placement Warrant;

 

WHEREAS, the parties wish
to enter into this Agreement, pursuant to which the Purchaser shall (i) subscribe for and purchase from the Company, Private Placement
Warrants (the “Subscribed Securities”) at the IPO Closing and (ii) receive from the Company, in connection with
the purchase of Private Placement Warrants and Public Units at the IPO Closing, shares of the Company’s Class B common stock,
par value $0.0001 per share (“Class B Common Stock” or “Founder Shares” and collectively with
the Class A Common Stock, the “Common Stock”), and additional Private Placement Warrants at the IPO Closing for
no additional consideration, as further described herein;

 

WHEREAS, the Company and the
Sponsor have entered into or intend to concurrently with this Agreement enter into agreements (collectively, the “Subscription
Agreements”) in the form of this Agreement with certain affiliates of the Purchaser (together with the Purchaser, the “Subscribing
Parties”) for the purchase of Founder Shares and Private Placement Warrants set forth therein; and

 

     

     

    

 

WHEREAS, the Company, the
Sponsor and the Subscribing Parties intend for the purchase of Founder Shares and Private Placement Warrants as set forth herein to be
made pursuant to Section 4(a)(1) and Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities
Act”), respectively.

 

NOW, THEREFORE, in consideration
of the premises, representations, warranties and the mutual covenants contained in this Agreement, and for other good and valuable consideration,
the receipt, sufficiency and adequacy of which are hereby acknowledged, the parties hereto agree as follows:

 

1.            Sale
and Purchase.

 

(a)            Securities.

 

(i)       Subject
to the terms and conditions hereof, the Purchaser hereby irrevocably subscribes for and agrees to purchase from the Company, and the Company
agrees to issue and sell to the Purchaser, the number of Private Placement Warrants set forth on Schedule A hereto for the
aggregate purchase price set forth on Schedule A hereto (the “Initial Purchase Price”).

 

(ii)      The
Purchaser acknowledges that the Subscribed Securities, the Additional Securities (as defined below), and any securities of the Company
that may be distributed to the Purchaser on account of the Subscribed Securities or the Additional Securities (such securities, together
with the Subscribed Securities and the Additional Securities, the “Securities”), will be subject to restrictions on
transfer as set forth in this Agreement.

 

(iii)     The
Company shall notify the Purchaser in writing of the anticipated date of the effectiveness of the Registration Statement (the “Effective
Date”) at least three (3) Business Days (as defined below) prior to the Effective Date, and the Purchaser shall remit the
Initial Purchase Price to the Company’s transfer agent (to be held in escrow pending the IPO Closing), by wire transfer of immediately
available funds or other means approved by the Company and the Purchaser, on the date that is one (1) Business Day prior to the Effective
Date, or such other date as the Company and the Purchaser may agree upon in writing; provided, however, that if the actual
number of Public Units offered and sold in the IPO is less than 15,000,000 (assuming a price per Public Unit of $10.00), then the Purchaser
shall not be obligated to remit the Initial Purchase Price as set forth in Section ‎1(a)(i) and any of the Purchaser,
the Company or the Sponsor may in its sole discretion terminate this Agreement which shall be of no further force or effect. As used herein,
 “Business Day” means any day, other than a Saturday or a Sunday, that is neither a legal holiday nor a day on which
banking institutions are generally authorized or required by law or regulation to close in the City of New York, New York. If the IPO
Closing has not occurred by the date that is seven (7) Business Days after the date on which the Purchaser remitted the Initial Purchase
Price to the Company’s transfer agent, then, unless the Purchaser otherwise agrees in writing, the Company will promptly cause its
transfer agent to return the Initial Purchase Price to the Purchaser. If the IPO Closing has not occurred by [•], 2021, this Agreement
shall terminate and be of no further force or effect.

 

(iv)     It
is currently contemplated that the IPO will raise $150,000,000 in gross proceeds (excluding exercise of the underwriter’s option
to purchase additional units in connection with the IPO (the “Over-allotment Option”)). The Purchaser and the Company
agree that if the size of the IPO is increased, the number of Private Placement Warrants to be purchased hereunder shall be adjusted on
a pro rata basis; provided, however, that in the event the IPO is contemplated to raise more than $207,000,000, then the
Purchaser shall not be obligated to remit the Initial Purchase Price as set forth in Section ‎1(a)(i)  and any
of the Purchaser, the Company or the Sponsor may in its sole discretion terminate this Agreement which shall be of no further force or
effect.

 

    2

     

    

 

(v)      In
the event that the underwriters’ over-allotment option in connection with the IPO (the “Over-allotment
Option”) is exercised, the Purchaser agrees to purchase such additional Private Placement Warrants as indicated on Schedule
A at the price per Private Placement Warrant set forth on Schedule A. The Company shall notify the Purchaser in writing
of the anticipated date of each closing of the exercise of the Over-allotment Option, if any (each, an “Over-allotment
Closing”), at least two (2) Business Days prior to such Over-allotment Closing (or, in the event that such
Over-allotment Closing is to occur simultaneously with the IPO Closing, as promptly as practicable), and the Purchaser shall pay the
purchase price for the Private Placement Warrants to be purchased in connection with such Over-allotment Closing (in the aggregate
and together with the Initial Purchase Price, the “Purchase Price”) by wire transfer of immediately available
funds or other means approved by the Company and the Purchaser on that date that is one (1) Business Day prior to such
Over-allotment Closing (to be held in escrow pending such Over-allotment Closing), or such other date as the Company and the
Purchaser may agree upon in writing. If the Over-allotment Closing has not occurred by the date that is seven (7) Business Days
after the date on which the Purchaser remitted purchase price for the Private Placement Warrants to be purchased in connection with
such Over-allotment Closing, then, unless the Purchaser otherwise agrees in writing, the Company will promptly cause its transfer
agent to return such amounts to the Purchaser.

 

(vi)     On
the date of the IPO Closing, the Company shall issue to the Purchaser the number of Private Placement Warrants as set forth on Schedule
A hereto (without including any additional Private Placement Warrants to be purchased in the event that the Over-allotment Option
is exercised). On the date of each Over-allotment Closing, if any, the Company shall issue to Purchaser the number of Private Placement
Warrants to be purchased in the event of each such Over-allotment Closing as set forth on Schedule A.

 

(b)            Additional
Securities. On the date of the IPO Closing, the Company shall issue to the Purchaser the number of additional Private Placement Warrants
and the number of Founder Shares as indicated on Schedule B for no consideration. In the event the Over-allotment Option is exercised,
the number of such securities to be issued shall be increased so that the Private Placement Warrants to be issued pursuant to this Section 1(b) shall
represent 5% of all Private Placement Warrants to be issued and outstanding and the Founder Shares to be issued pursuant to this Section 1(b) shall
represent 10% of all Founder Shares to be issued and outstanding. The additional Private Placement Warrants and Founder Shares to be issued
pursuant to this Section 1(b) are collectively referred to as the “Additional Securities”. Prior to
the issuance of the Additional Securities to the Purchaser pursuant to this Section 1(b), the Sponsor shall transfer (or forfeit)
a corresponding amount of such Additional Securities to the Company. For U.S. federal income tax purposes, the Purchaser, the Sponsor
and the Company intend to treat the issuance of Additional Securities by the Company to the Purchaser as being made in connection with
the purchase of the Subscribed Securities and the Public Units on the date of the IPO Closing. Consistent with such treatment, the parties
intend for the acquisition of the Additional Securities, the Subscribed Securities and the Public Units to be treated as the acquisition
of an investment unit consisting of such securities on the date of the IPO Closing.

 

(c)            Closing
Conditions. The Purchaser’s obligation to purchase the Private Placement Warrants hereunder and the Company’s obligation
to sell the Private Placement Warrants and to issue the Additional Securities to the Purchaser is conditioned upon satisfaction of the
following conditions precedent (any or all of which may be waived by the Company, the Sponsor and the Purchaser in its sole discretion
with respect to the other parties’ conditions):

 

(i)       On
the IPO Closing or an Over-allotment Closing, as applicable, no legal, administrative or regulatory action, suit or proceeding shall be
pending which seeks to restrain or prohibit the transactions contemplated by this Agreement;

 

(ii)      The
representations and warranties of the Company, the Sponsor and the Purchaser contained in this Agreement shall have been true and correct
on the date of this Agreement and shall be true and correct on the IPO Closing or Over-allotment Closing, as applicable, as if made on
the date of such closing (other than the representations and warranties set forth in Sections ‎4(b) and ‎4(h),
which shall be true and correct as of the date hereof and the IPO Closing, respectively); and

 

(iii)     In
the case of the Company and the Sponsor, each Subscribing Party other than the Purchaser shall have on the IPO Closing or Over-allotment
Closing, as applicable, concurrently consummated its subscription under its Subscription Agreement.

 

(d)            Delivery
of Securities.

 

(i)       The
Company shall register the Purchaser as the owner of the Subscribed Securities and the Additional Securities with the Company’s
transfer agent by book entry upon the purchase thereof (provided that prior to the Company’s appointment of a transfer agent
it shall register the Purchaser as the owner of such securities in the Company’s share and/or warrant ledger upon the purchase thereof).

 

(ii)      Each
register and book-entry for the Securities shall contain a notation, and each certificate (if any) evidencing the Securities shall be
stamped or otherwise imprinted with a legend (in addition to any other required legends, as applicable), in substantially the following
form:

 

    3

     

    

 

“THE SECURITIES REPRESENTED HEREBY HAVE
NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS AND NEITHER THE SECURITIES
NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER SUCH ACT OR SUCH LAWS OR AN EXEMPTION FROM REGISTRATION UNDER SUCH ACT AND SUCH LAWS WHICH, IN THE OPINION OF COUNSEL
(WHICH THE COMPANY MAY WAIVE), IS AVAILABLE.”

 

“THE SECURITIES REPRESENTED BY THIS CERTIFICATE
ARE SUBJECT TO ADDITIONAL RESTRICTIONS ON TRANSFER SET FORTH IN A SUBSCRIPTION AGREEMENT BY AND AMONG THE HOLDER AND THE OTHER PARTIES
THERETO. COPIES OF SUCH AGREEMENT MAY BE OBTAINED UPON WRITTEN REQUEST TO THE SECRETARY OF THE COMPANY.”

 

(e)            Legend
Removal. Following the expiration of the transfer restrictions set forth in Section ‎6(a), if the Securities
are eligible to be sold without restriction under, and without the Company being in compliance with the current public information requirements
of, Rule 144 under the Securities Act, or if they are registered for resale under the Securities Act pursuant to a shelf registration
statement, then at the Purchaser’s written request, the Company will use commercially reasonable efforts to cause the Company’s
transfer agent to remove the legend set forth in Section ‎1(d)(ii), subject to compliance by the Purchaser with the
reasonable and customary procedures for such removal required by the Company or its transfer agent. In connection therewith, if required
by the Company’s transfer agent, the Company will promptly cause an opinion of counsel to be delivered to and maintained with its
transfer agent, together with any other authorizations, certificates and directions required by the transfer agent that authorize and
direct the transfer agent to issue such Securities without any such legend.

 

(f)             Registration
Rights. On the Effective Date, the Company shall enter into a Registration Rights Agreement (the “Registration Rights Agreement”)
with the Sponsor, the Subscribing Parties and certain other parties thereto, in substantially the form provided to the Purchaser prior
to the date hereof. The Registration Rights Agreement shall provide the Purchaser with registration rights with respect to the Subscribed
Securities and Additional Securities that are no less favorable to the Purchaser than the registration rights of the Sponsor set forth
therein.

 

2.            Potential
Forfeiture.

 

(a)            If
(i)(x) the Purchaser, the Subscribing Parties and their affiliates do not beneficially own or hold, directly or indirectly, at
least 9.999% of the Public Shares (the “Anchor Threshold”) either as of the date of the vote by the
Company’s stockholders to approve the Business Combination or as of the Business Day immediately prior to the Business
Combination Closing (as defined below) or (y) the Purchaser redeems all or a portion of its Public Shares in connection with
the Business Combination that results in the Purchaser, the Subscribing Parties and their affiliates collectively owning less than
the Anchor Threshold and (ii) the Purchaser does not either (x) at the Business Combination Closing, purchase Units for
$25.0 million of Aggregate Purchase Price (each as defined in that certain Forward Purchase Agreement, entered into as of
[DATE], by and between the Company and the Purchaser (the “Forward Purchase Agreement”) (for reasons other
than those described in Section 1 of the Forward Purchase Agreement) pursuant to the Forward Purchase Agreement, or
(y) execute an alternative financing in connection with the Business Combination (as described in Section 1(d) of the
Forward Purchase Agreement) under terms mutually agreed upon by the Purchaser, the Company and the Sponsor, then the [Sponsor] shall
have the right at its sole discretion to repurchase the Purchaser’s Private Placement Warrants for 50% of the Purchase Price
within the thirty (30) days following the Business Combination Closing (the “Repurchase Right”); provided
that in the event that Edward R. Smith and Wayne Kawarabayashi both no longer serve as the Chief Executive Officer and Chief
Financial Officer, respectively, of the Company as of the Business Day immediately prior to the Business Combination Closing, the
Sponsor shall forfeit the Repurchase Right. The Purchaser shall take all actions as may be reasonably necessary to consummate any
transfer and/or sale of the Private Placement Warrants and Founder Shares contemplated by this Section ‎2(a),
including entering into agreements and delivering certificates, instruments and consents as may be deemed by the Company to be
necessary or appropriate (which shall not require the Purchaser to make any representations other than as to its clear title to the
applicable Private Placement Warrants and Founder Shares and its power and authorization to effect the transactions contemplated by
the applicable agreement or other instrument).

 

    4

     

    

 

(b)            The
Purchaser agrees that if, in order to facilitate a Business Combination, the Sponsor decides (i) to forfeit, transfer to a third
person, exchange, subject to transfer, vesting or conditional forfeiture provisions or amend the terms of all or any portion of the Founder
Shares or (ii) to enter into any other arrangements with respect to the Founder Shares (including, without limitation, a transfer
of the Sponsor’s membership interests representing an interest in any of the foregoing), including voting in favor of any amendment
to the terms of the Founder Shares (each, a “Change in Investment”), such Change in Investment shall apply pro rata
to the Purchaser, the Sponsor and the other holders, if any (other than the independent directors of the Company), based on the relative
number of Founder Shares to be held by each on the Business Combination Closing. The Purchaser agrees to take all steps and execute all
such agreements as may be necessary or reasonably requested by the Sponsor to effectuate such Change in Investment on substantially the
same terms and conditions as applicable to the Sponsor. For the avoidance of doubt, no Change in Investment shall result in the Purchaser
having to forfeit or transfer any Private Placement Warrants.

 

3.            Representations
and Warranties of the Purchaser. The Purchaser represents and warrants to the Company as follows, as of the date hereof:

 

(a)            Organization
and Power. The Purchaser is duly organized, validly existing and in good standing under the laws of the jurisdiction of its formation
and has all requisite power and authority to carry on its business as presently conducted and as proposed to be conducted.

 

(b)            Authorization.
The Purchaser has full power and authority to enter into this Agreement. This Agreement, when executed and delivered by the Purchaser,
will constitute the valid and legally binding obligation of the Purchaser, enforceable against the Purchaser in accordance with its terms,
except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance and any other laws
of general application affecting enforcement of creditors’ rights generally or (ii) as limited by laws relating to the availability
of specific performance, injunctive relief or other equitable remedies.

 

(c)            Governmental
Consents and Filings. No consent, approval, order or authorization of, or registration, qualification, designation, declaration or
filing with, any federal, state or local governmental authority is required on the part of the Purchaser in connection with the consummation
of the transactions contemplated by this Agreement, except for filings pursuant to applicable securities laws, rules or regulations.

 

(d)            Compliance
with Other Instruments. The execution, delivery and performance by the Purchaser of this Agreement and the consummation by the Purchaser
of the transactions contemplated by this Agreement will not result in any violation or default (i) under any provisions of its organizational
documents, (ii) under any instrument, judgment, order, writ or decree to which it is a party or by which it is bound, (iii) under
any note, indenture or mortgage to which it is a party or by which it is bound, (iv) under any lease, agreement, contract or purchase
order to which it is a party or by which it is bound or (v) under any provision of federal or state statute, rule or regulation
applicable to the Purchaser, in each case (other than clause ‎(i)), which would have a material adverse effect on the Purchaser’s
ability to consummate the transactions contemplated by this Agreement.

 

(e)            Purchase
Entirely for Own Account. This Agreement is made with the Purchaser in reliance upon the Purchaser’s representation to the Company,
which by the Purchaser’s execution of this Agreement, the Purchaser hereby confirms, that the Securities to be acquired by the Purchaser
will be acquired for investment for the Purchaser’s own account, not as a nominee or agent, and not with a view to the resale or
distribution of any part thereof in violation of any state or federal securities laws, and that the Purchaser has no present intention
of selling, granting any participation in or otherwise distributing the same in violation of law. By executing this Agreement, the Purchaser
further represents that the Purchaser does not presently have any contract, undertaking, agreement or arrangement with any Person (other
than the Company) to sell, transfer or grant participations to such Person or to any third Person, with respect to any of the Securities.
For purposes of this Agreement, “Person” means an individual, a limited liability company, a partnership, a joint venture,
a corporation, a trust, an unincorporated organization, any other entity or any government or any department or agency thereof.

 

(f)            Disclosure
of Information. The Purchaser has had an opportunity to discuss the Company’s business, management, financial affairs and the
terms and conditions of the offering of the Securities, as well as the terms of the Company’s proposed IPO, with the Company’s
management.

 

    5

     

    

 

(g)            Restricted
Securities. The Purchaser understands that the offer and sale of the Securities to the Purchaser has not been and will not be registered
under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends upon,
among other things, the bona fide nature of the investment intent and the accuracy of the Purchaser’s representations as expressed
herein. The Purchaser understands that the Securities are “restricted securities” under applicable U.S. federal and state
securities laws and that, pursuant to these laws, the Purchaser must hold the Securities indefinitely unless they are registered with
the Commission and qualified by state authorities, or an exemption from such registration and qualification requirements is available.
The Purchaser acknowledges that the Company has no obligation to register or qualify the Securities except pursuant to the Registration
Rights Agreement. The Purchaser further acknowledges that if an exemption from registration or qualification is available, it may be conditioned
on various requirements including, but not limited to, the time and manner of sale, the holding period for the Securities, and on
requirements relating to the Company which are outside of the Purchaser’s control, and which the Company is under no obligation
and may not be able to satisfy. The Purchaser acknowledges that the Company has filed the Registration Statement for its proposed IPO.
The Purchaser understands that the offering of Securities and transactions contemplated hereunder are not and are not intended to be part
of the IPO, and that the Purchaser will not be able to rely on the protection of Section 11 of the Securities Act with respect to
its purchase of Securities hereunder.

 

(h)            No
Public Market. The Purchaser understands that no public market now exists for the Securities, and that the Company has not made any
assurances that a public market will ever exist for the Securities.

 

(i)            High
Degree of Risk. The Purchaser understands that the purchase of the Subscribed Securities involves a high degree of risk which could
cause the Purchaser to lose all or part of its investment.

 

(j)            Accredited
Investor. The Purchaser is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities
Act.

 

(k)            No
General Solicitation. Neither the Purchaser, nor any of its officers, directors, employees, agents, stockholders or partners has either
directly or indirectly, including, through a broker or finder (i) to its knowledge, engaged in any general solicitation or (ii) published
any advertisement in connection with the offer and sale of the Securities.

 

(l)            Place
of Investment Decision. The Purchaser’s investment decision was made in the office or offices located at the address of the
Purchaser set forth on the signature page hereof.

 

(m)            Adequacy
of Financing.  The Purchaser will, when such funds are due hereunder, have sufficient funds to satisfy its obligations under
this Agreement.

 

(n)            No
Other Representations and Warranties; Non-Reliance. Except for the specific representations and warranties contained in this Section ‎3 and
in any certificate or agreement delivered pursuant hereto, none of the Purchaser nor any person acting on behalf of the Purchaser nor
any of the Purchaser’s affiliates (the “Purchaser Parties”) has made, makes or shall be deemed to make any other
express or implied representation or warranty with respect to the Purchaser and this offering, and the Purchaser Parties disclaim any
such representation or warranty. Except for the specific representations and warranties expressly made by the Company and the Sponsor
in Section ‎4 and Section ‎5 of this Agreement, respectively, and in any certificate or agreement
delivered pursuant hereto, the Purchaser Parties specifically disclaim that they are relying upon any other representations or warranties
that may have been made by the Company, any person on behalf of the Company or any of the Company’s affiliates (collectively, the
 “Company Parties”) or by the Sponsor, any person on behalf of the Sponsor or any of the Sponsor’s affiliates
(collectively, the “Sponsor Parties”) with respect to the transactions contemplated hereby.

 

4.            Representations,
Warranties and Covenants of the Company. The Company represents, warrants and covenants to the Purchaser as follows:

 

(a)            Organization
and Corporate Power. The Company is incorporated and validly existing and in good standing as a corporation under the laws of the
State of Delaware and has all requisite corporate power and authority to carry on its business as presently conducted and as proposed
to be conducted.

 

(b)            Capitalization.
The authorized share capital of the Company comprises, as of the date hereof:

 

(i)       200,000,000
shares of Class A Common Stock, none of which are issued and outstanding;

 

    6

     

    

 

(ii)      20,000,000
shares of Class B Common Stock, 4,312,500 of which are issued and outstanding and held by the Sponsor. All of the outstanding shares
of Class B Common Stock have been duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable
federal and state securities laws.

 

(iii)     1,000,000
shares of preferred stock, none of which is issued and outstanding.

 

(c)            Authorization.
All corporate action required to be taken by the Company’s Board of Directors and stockholders in order to authorize the Company
to enter into this Agreement, and to issue the Subscribed Securities and Additional Securities, has been taken on or prior to the date
hereof. All action on the part of the stockholders, directors and officers of the Company necessary for the execution and delivery of
this Agreement, the performance of all obligations of the Company under this Agreement, and the issuance and delivery of the Subscribed
Securities and Additional Securities has been taken on or prior to the date hereof. This Agreement, when executed and delivered by the
Company, shall constitute the valid and legally binding obligation of the Company, enforceable against the Company in accordance with
its terms except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance or other
laws of general application relating to or affecting the enforcement of creditors’ rights generally or (ii) as limited by laws
relating to the availability of specific performance, injunctive relief or other equitable remedies.

 

(d)            Valid
Issuance of Securities.

 

(i)       The
Subscribed Securities and Additional Securities, when issued, sold and delivered in accordance with the terms and for the
consideration set forth in this Agreement, will be validly issued and fully paid, as applicable, and free of all preemptive or
similar rights, taxes, liens, encumbrances and charges with respect to the issue thereof and restrictions on transfer other than
restrictions on transfer specified under this Agreement, applicable state and federal securities laws and liens or encumbrances
created by or imposed by the Purchaser. Assuming the accuracy of the representations of the Purchaser in this Agreement and subject
to the filings described in Section ‎4(f) below, the Subscribed Securities and Additional
Securities will be issued in compliance with all applicable federal and state securities laws, rules and regulations.

 

(ii)      The
Founder Shares to be issued to the Purchaser will not subject the Purchaser to personal liability upon its acquisition of such Founder
Shares by reason of being a holder of such Founder Shares.

 

(iii)     No
 “bad actor” disqualifying event described in Rule 506(d)(1)(i)-(viii) of the Securities Act (a “Disqualification
Event”) is applicable to the Company or, to the Company’s knowledge, any Company Covered Person (as defined below), except
for a Disqualification Event as to which Rule 506(d)(2)(ii–iv) or (d)(3), is applicable. “Company Covered Person”
means, with respect to the Company as an “issuer” for purposes of Rule 506 promulgated under the Securities Act, any
Person listed in the first paragraph of Rule 506(d)(1).

 

(e)            IPO.
The offers and sales of securities in the IPO will be made pursuant to an effective Registration Statement and otherwise in compliance
with the Securities Act and the rules and regulations promulgated thereunder and applicable state securities laws, rules and
regulations.

 

(f)            Governmental
Consents and Filings. Assuming the accuracy of the representations made by the Purchaser in this Agreement, no consent, approval,
order or authorization of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental
authority is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement,
except for filings pursuant to Regulation D of the Securities Act and applicable state securities laws, if any.

 

(g)            Compliance
with Other Instruments. The execution, delivery and performance of this Agreement and the consummation of the transactions contemplated
by this Agreement will not result in any violation or default (i) under any provisions of the certificate of incorporation, bylaws
or other governing documents of the Company, (ii) under any instrument, judgment, order, writ or decree to which the Company is a
party or by which it is bound, (iii) under any note, indenture or mortgage to which the Company is a party or by which it is bound,
(iv) under any lease, agreement, contract or purchase order to which the Company is a party or by which it is bound or (v) under
any provision of federal or state statute, rule or regulation applicable to the Company, in each case (other than clause ‎(i))
which would have a material adverse effect on the Company or its ability to consummate the transactions contemplated by this Agreement.

 

    7

     

    

 

(h)            Operations.
As of the date hereof, the Company has not conducted, and prior to the IPO Closing the Company will not conduct, any operations other
than organizational activities and activities in connection with offerings of the Securities.

 

(i)            Foreign
Corrupt Practices. Neither the Company, nor any director, officer, agent, employee or other Person acting on behalf of the Company
has, in the course of its actions for, or on behalf of, the Company (i) used any corporate funds for any unlawful contribution, gift,
entertainment or other unlawful expenses relating to political activity; (ii) made any direct or indirect unlawful payment to any
foreign or domestic government official or employee from corporate funds; (iii) violated or is in violation of any provision of the
U.S. Foreign Corrupt Practices Act of 1977, as amended; or (iv) made any unlawful bribe, rebate, payoff, influence payment, kickback
or other unlawful payment to any foreign or domestic government official or employee.

 

(j)            Compliance
with Anti-Money Laundering Laws. The operations of the Company are and have been conducted at all times in compliance with
applicable financial recordkeeping and reporting requirements and all other applicable U.S. and non-U.S. anti-money laundering laws
and regulations, including, but not limited to, those of the Currency and Foreign Transactions Reporting Act of 1970, as amended,
the USA Patriot Act of 2001 and the applicable money laundering statutes of all applicable jurisdictions, the rules and
regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any
governmental agency (collectively, the “Anti-Money Laundering Laws”), and no action, suit or proceeding by or
before any court or governmental agency, authority or body or any arbitrator involving the Company with respect to the Anti-Money
Laundering Laws is pending or, to the knowledge of the Company, threatened.

 

(k)            Absence
of Litigation. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency,
self-regulatory organization or body pending or, to the knowledge of the Company, threatened against or affecting the Company or any of
the Company’s officers or directors, whether of a civil or criminal nature or otherwise, in their capacities as such.

 

(l)            No
General Solicitation. Neither the Company nor any of its officers, directors, employees, agents or stockholders has either directly
or indirectly, including, through a broker or finder (i) engaged in any general solicitation or (ii) published any advertisement
in connection with the offer and sale of the Subscribed Securities or Additional Securities.

 

(m)            Non-Public
Information. The Company represents and warrants that none of the information conveyed to the Purchaser in connection with the transactions
contemplated by this Agreement will constitute material non-public information of the Company upon the effectiveness of the Registration
Statement.

 

(n)            No
Other Representations and Warranties; Non-Reliance. Except for the specific representations and warranties contained in this Section ‎4 and
in any certificate or agreement delivered pursuant hereto, none of the Company Parties has made, makes or shall be deemed to make any
other express or implied representation or warranty with respect to the Company or the offering of Securities hereunder, and the Company
Parties disclaim any such representation or warranty. Except for the specific representations and warranties expressly made by the Purchaser
in Section ‎3 of this Agreement and in any certificate or agreement delivered pursuant hereto, the Company
Parties specifically disclaim that they are relying upon any other representations or warranties that may have been made by the Purchaser
Parties.

 

5.            Representations,
Warranties and Covenants of the Sponsor. The Sponsor represents, warrants and covenants as follows:

 

(a)            Organization
and Power. The Sponsor is duly organized, validly existing and in good standing as a limited liability company under the laws of the
State of Delaware and has all requisite power and authority to carry on its business as presently conducted and as proposed to be conducted.

 

    8

     

    

 

(b)            Authorization.
The Sponsor has full power and authority to enter into this Agreement. This Agreement, when executed and delivered by the Sponsor, will
constitute the valid and legally binding obligation of the Sponsor, enforceable against the Sponsor in accordance with its terms, except
(i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance and any other laws of general
application affecting enforcement of creditors’ rights generally or (ii) as limited by laws relating to the availability of
specific performance, injunctive relief or other equitable remedies.

 

(c)            No
Other Representations and Warranties; Non-Reliance. Except for the specific representations and warranties contained in this Section ‎5 and
in any certificate or agreement delivered pursuant hereto, none of the Sponsor Parties has made, makes or shall be deemed to make any
other express or implied representation or warranty with respect to the Sponsor or the offering of Securities hereunder, and the Sponsor
Parties disclaim any such representation or warranty. Except for the specific representations and warranties expressly made by the Purchaser
in Section ‎3 of this Agreement and in any certificate or agreement delivered pursuant hereto, the Sponsor
Parties specifically disclaim that they are relying upon any other representations or warranties that may have been made by the Purchaser
Parties.

 

6.            Additional
Agreements and Acknowledgements of the Purchaser.

 

(a)            Transfer
Restrictions.  The Purchaser agrees that, except for Transfers (as defined below) to third parties required pursuant to Section ‎2 above,
it shall not Transfer (i) any Founder Shares (or any shares of Class A common stock issuable upon conversion thereof)
until the earlier of (A) one year after the completion of the Business Combination (the “Business Combination
Closing”) or (B) subsequent to the Business Combination Closing, (x) if the last sale price of the Class A
Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations
and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Business Combination
Closing or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other
similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of
Class A Common Stock for cash, securities or other property (such period, the “Founder Shares Lock-up
Period”) or (ii) any Private Placement Warrants (or shares of Common Stock issued or issuable upon the exercise of
the Private Placement Warrants) until 30 days after the Business Combination Closing (such period, the “Private Placement
Warrants Lock-up Period” and together with the Founder Shares Lock-up Period, the “Lock-up Periods”).
Notwithstanding the provisions set forth above in this Section ‎6(a), Transfers of the Securities are permitted
(i) to the Company’s officers or directors, any affiliates or family members of any of the Company’s officers or
directors, any members or partners of the Sponsor or their affiliates (including members of the Sponsor’s members), any
affiliates of the Sponsor, or any employees of such affiliates; (ii) in the case of an individual, by gift to a member of such
person’s immediate family or to a trust, the beneficiary of which is a member of such person’s immediate family, an
affiliate of such person or to a charitable organization; (iii) in the case of an individual, by virtue of laws of descent and
distribution upon death of such person; (iv) in the case of an individual, pursuant to a qualified domestic relations order;
(v) by private sales or transfers made in connection with the consummation of a Business Combination at prices no greater than
the price at which the Private Placement Warrants or shares of Class A Common Stock, as applicable, were originally purchased;
(vi)  by virtue of the laws of the State of Delaware or the Sponsor’s, or the Purchaser’s organizational documents upon liquidation or
dissolution of the Sponsor or the Purchaser, as applicable; (vii) to the Company for no value for cancellation in connection with the consummation of the
Business Combination; (viii) in the event of the Company’s liquidation prior to its consummation of the Business
Combination; (ix) in the event of the Company’s completion of a liquidation, merger, capital stock exchange or other
similar transaction which results in all of the Company’s stockholders having the right to exchange their Common Sstock for
cash, securities or other property subsequent to the completion of the Business Combination; or (x) to the Purchaser’s
affiliates, to any investment fund or other entity controlled or managed by the Purchaser, or to any investment manager or
investment advisor of the Purchaser or an affiliate of any such investment manager or investment advisor or to any investment fund
or other entity controlled or managed by such persons (each of the foregoing, a “Permitted Transferee”); provided, however,
that in the case of clauses ‎(i) through ‎(vi) and ‎(x) these Permitted Transferees must enter into
a written agreement with the Company agreeing to be bound by the transfer restrictions herein and the other restrictions contained
in this Agreement (including provisions relating to voting, the Trust Account and liquidating distributions). Notwithstanding the
foregoing, (i) in the event the foregoing transfer restrictions relating to the Founder Shares or Private Placement Warrants
(or the Class A Common Stock to which such securities relate) are changed as applicable to the Sponsor or any other holder of
Founder Shares or Private Placement Warrants between the time this Agreement is executed and the consummation of the IPO, the
foregoing transfer restrictions shall be deemed replaced and superseded by the actual transfer restrictions imposed on such
securities in effect at the consummation of the IPO and (ii) in the event the Sponsor or any of its affiliates are no longer
subjected to the foregoing transfer restrictions with respect to such securities at any time, then the Purchaser’s
corresponding Securities shall also no longer be subjected to such restrictions to the extent the Sponsor or its affiliates are no
longer subjected to such restrictions and in proportionate amount commensurate with its relative ownership of the Founder Shares and
Private Placement Warrants (or any securities into which they have been converted). As used in this Agreement,
 “Transfer” shall mean the (x) sale of, offer to sell, contract or agreement to sell, hypothecate, pledge,
grant of any option to purchase or otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment or
increase of a put equivalent position or liquidation with respect to or decrease of a call equivalent position within the meaning of
Section 16 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules and
regulations of the Commission promulgated thereunder with respect to, any of the Securities; (y) entry into any swap or other
arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any of the Securities,
whether any such transaction is to be settled by delivery of such Securities, in cash or otherwise, or (z) public announcement
of any intention to effect any transaction specified in clause ‎(x) or (y) (and “Transferee”
shall have a corresponding meaning); provided further, that this Section ‎6(a) shall not prohibit the
Purchaser from effecting a Short Sale (as defined below) with securities that do not constitute “Securities” under this
Agreement.

 

    9

     

    

 

(b)            Trust
Account. The Purchaser hereby acknowledges that it is aware that the Company will establish the Trust Account for the benefit of its
public stockholders upon the IPO Closing. The Purchaser hereby agrees that it shall have no right of set-off or any right, title, interest
or claim of any kind (“Claim”) to, or to any monies in, the Trust Account, and hereby irrevocably waives any Claim
to, or to any monies in, the Trust Account that it may have now or in the future, except for redemption and liquidation rights, if any,
the Purchaser may have in respect of any Public Shares held by it. In the event the Purchaser has any Claim against the Company under
this Agreement, the Purchaser shall pursue such Claim solely against the Company and its assets outside the Trust Account and not against
the property or any monies in the Trust Account, except for redemption and liquidation rights, if any, the Purchaser may have in respect
of any Public Shares held by it.

 

(c)            Short
Sales. Other than the restrictions on transfer pursuant to the Securities Act and set forth in Section 6(a), the Purchaser
shall not be required to execute any lock-up or similar agreement or otherwise be subject to any contractual restriction on the ability
to offer, sell, pledge, contract to sell, sell any option, engage in hedging activities or execute any “short sales” as defined
in Rule 200 of Regulation SHO under the Exchange Act with respect to the Securities.

 

(d)            Use
of Purchaser’s Name. Neither the Company nor the Sponsor will, without the written consent of the Purchaser in each instance
(which consent shall not be unreasonably withheld, conditioned or delayed), use in advertising, publicity or otherwise the name
of the Purchaser or any of its affiliates, or any director, officer or employee of the Purchaser, nor any trade name, trademark, trade
device, service mark, symbol or any abbreviation, contraction or simulation thereof owned by the Purchaser or its affiliates or any information
relating to the business or operations of the Purchaser or its affiliates (including, for the avoidance of doubt, any investment vehicles,
funds or accounts managed thereby). Notwithstanding the foregoing, the Company may disclose (i) the Purchaser’s name and information
concerning the Purchaser (A) to the extent required by law, regulation or regulatory request, including in the Registration Statement
or (B) to the Company’s lawyers, independent accountants and to other advisors and service providers who reasonably require
the Purchaser’s information in connection with the provision of services to the Company, are advised of the confidential nature
of such information and are obligated to keep such information confidential, and (ii) the Purchaser’s name and the terms of
this Agreement to the other Subscription Parties. The Company and the Sponsor agree to provide to the Purchaser for the Purchaser’s
review any disclosure in any registration statement, proxy statement or other document in advance of the submission, filing or disclosure
of such document in connection with the transactions contemplated by this Agreement with respect to the Purchaser or any of its affiliates,
and will not make any such submission, filing or disclosure without including any revisions reasonably requested in writing by the Purchaser
or to the extent the Purchaser has a good faith objection to such submission, filing or disclosure.

 

(e)            Standstill.
The Purchaser hereby agrees that it shall not transfer, assign or sell any of its Public Shares acquired in the IPO until the earlier
of (i) 30 days after the initial announcement of the Business Combination or (ii) the date on which the last sale price of the
Class A Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations
and the like) for any 20 trading days within any 30-trading day period.

 

(f)             Founder Shares Voting and Redemption. The Purchaser agrees
that if the Company seeks stockholder approval of a proposed Business Combination, then in connection with such proposed Business Combination,
it shall (i) vote any of the Founder Shares
owned by it in favor of any proposed Business Combination (including any proposals recommended by the Company's board of directors
in connection with such Business Combination) and (ii) not redeem any Founder Shares owned by it in connection with such stockholder approval. If the Company seeks to consummate
a proposed Business Combination by engaging in a tender offer, the Purchaser agrees that it will not sell or
tender any Founder Shares owned by it in connection therewith.

 

(g)            Liquidating Distributions. The Purchaser acknowledges that
it has no right, title, interest or claim of any kind in or to any monies held in the Trust Account or any other asset of the
Company as a result of any liquidation of the Company with respect to the Founder Shares held by it, him or her. The Purchaser hereby further waives, with respect to any Founder Shares held by it,  any redemption rights it may have in connection with (A) the consummation of a Business Combination, including, without limitation, any such rights available
in the context of a stockholder vote to approve such Business Combination, or (B) a stockholder vote to approve an amendment to the Charter
to modify the substance or timing of the Company's obligation to allow redemption in connection with the Company's initial Business Combination
or to redeem 100% of the Public Shares if the Company has not consummated a Business Combination within the time period set forth in
the Charter or with respect to any other provision relating to stockholders' rights or pre-initial Business Combination activity or in
the context of a tender offer made by the Company to purchase Public Shares (although the Purchaser and its affiliates shall be entitled
to redemption and liquidation rights with respect to any Public Shares it or they hold if the Company fails to consummate a Business
Combination within the time period set forth in the Charter).

 

(h)            Most
Favored Nation. None of the Sponsor, the Company or any of their affiliates will enter into any arrangement, agreement or understanding
containing terms relating to the subscription of Founder Shares and/or Private Placement Warrants that are more favorable to the counterparty
or offeree than the terms set forth in this Agreement.

 

    10

     

    

 

7.            General
Provisions.

 

(a)            Notices.
All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively given
upon the earlier of actual receipt, or (i) personal delivery to the party to be notified, (ii) when sent, if sent by electronic
mail during normal business hours of the recipient, and if not sent during normal business hours, then on the recipient’s next Business
Day, (iii) five (5) Business Days after having been sent by registered or certified mail, return receipt requested, postage
prepaid, or (iv) one (1) Business Day after deposit with a nationally recognized overnight courier, freight prepaid, specifying
next Business Day delivery, with written verification of receipt.

 

All communications sent to
the Company shall be sent to:

 

USA Acquisition Corp.

1 Embarcadero Center

Suite 950

San Francisco, CA 94111

Attn: Edward R. Smith

Email: ted.smith@usaadvisors.com

 

with a copy to:

 

Paul Hastings LLP

200 Park Avenue

New York, New York 10166

Attn: Frank Lopez

Email: franklopez@paulhastings.com

 

All
communications to the Purchaser shall be sent to the Purchaser’s mailing address or email address as set forth on the signature
page hereto, or to such email address, facsimile number (if any) or address as subsequently modified by written notice given in accordance
with this Section ‎7(a).

 

(b)            No
Finder’s Fees. Each party represents that it neither is nor will be obligated for any finder’s fee or commission in connection
with this transaction. The Purchaser agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation
in the nature of a finder’s or broker’s fee arising out of this transaction (and the costs and expenses of defending against
such liability or asserted liability) for which the Purchaser or any of its officers, employees or representatives are responsible. The
Company agrees to indemnify and hold harmless the Purchaser from any liability for any commission or compensation in the nature of a finder’s
or broker’s fee arising out of this transaction (and the costs and expenses of defending against such liability or asserted liability)
for which the Company or any of its officers, employees or representatives is responsible.

 

(c)            Survival.
All of the representations and warranties contained herein shall survive the consummation of the transactions contemplated by this Agreement.

 

(d)            Entire
Agreement. This Agreement, together with any other documents, instruments and writings that are delivered pursuant hereto or referenced
herein, constitutes the entire agreement and understanding of the parties hereto in respect of its subject matter and supersedes all prior
understandings, agreements or representations by or among the parties hereto, written or oral, to the extent they relate in any way to
the subject matter hereof or the transactions contemplated hereby.

 

(e)            Successors.
All of the terms, agreements, covenants, representations, warranties and conditions of this Agreement are binding upon, and inure to the
benefit of and are enforceable by, the parties hereto and their respective successors. Nothing in this Agreement, express or implied,
is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations
or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement.

 

    11

     

    

 

(f)            Assignments.
Except as otherwise specifically provided herein, no party hereto may assign either this Agreement or any of its rights, interests, or
obligations hereunder without the prior written approval of the other party.

 

(g)            Counterparts.
This Agreement may be executed in two or more counterparts, each of which will be deemed an original but all of which together will constitute
one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including any electronic signature covered
by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable
Law, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly
delivered and be valid and effective for all purposes.

 

(h)            Headings.
The section headings contained in this Agreement are inserted for convenience only and will not affect in any way the meaning or interpretation
of this Agreement.

 

(i)            Governing
Law. This Agreement, the entire relationship of the parties hereto, and any litigation between the parties (whether grounded in contract,
tort, statute, law or equity) shall be governed by, construed in accordance with, and interpreted pursuant to the laws of the State of
New York, without giving effect to conflicts of law principles that would result in the application of the substantive laws of another
jurisdiction.

 

(j)            Jurisdiction.
The parties hereby irrevocably and unconditionally (i) submit to the jurisdiction of the state courts of New York and the United
States District Court for the Southern District of New York for the purpose of any suit, action or other proceeding arising out of or
based upon this Agreement, (ii) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement
except in state courts of New York or the United States District Court for the Southern District of New York, and (iii) waive, and
agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject
personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution, that the
suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this
Agreement or the subject matter hereof may not be enforced in or by such court.

 

(k)            WAIVER
OF JURY TRIAL. THE PARTIES HERETO HEREBY WAIVE ANY RIGHT TO A JURY TRIAL IN CONNECTION WITH ANY LITIGATION PURSUANT TO THIS AGREEMENT
AND THE TRANSACTIONS CONTEMPLATED HEREBY.

 

(l)            Amendments.
This Agreement may not be amended, modified or waived as to any particular provision, except with the prior written consent of the Company,
the Sponsor and the Purchaser.

 

(m)            Severability.
The provisions of this Agreement will be deemed severable and the invalidity or unenforceability of any provision will not affect the
validity or enforceability of the other provisions hereof; provided that if any provision of this Agreement, as applied to any
party hereto or to any circumstance, is adjudged by a governmental authority, arbitrator or mediator not to be enforceable in accordance
with its terms, the parties hereto agree that the governmental authority, arbitrator, or mediator making such determination will have
the power to modify the provision in a manner consistent with its objectives such that it is enforceable, and/or to delete specific words
or phrases, and in its reduced form, such provision will then be enforceable and will be enforced.

 

(n)            Expenses.
Each of the Company, the Sponsor and the Purchaser will bear its own costs and expenses incurred in connection with the preparation, execution
and performance of this Agreement and the consummation of the transactions contemplated hereby, including all fees and expenses of agents,
representatives, financial advisors, legal counsel and accountants. The Company shall be responsible for the fees of its transfer agent,
stamp taxes and all of The Depository Trust Company’s fees associated with the issuance of the Securities and the securities issuable
upon conversion or exercise of the Securities.

 

    12

     

    

 

(o)            Construction.
The parties hereto have participated jointly in the negotiation and drafting of this Agreement. If an ambiguity or question of
intent or interpretation arises, this Agreement will be construed as if drafted jointly by the parties hereto and no presumption or
burden of proof will arise favoring or disfavoring any party hereto because of the authorship of any provision of this Agreement.
Any reference to any federal, state, local or foreign law will be deemed also to refer to law as amended and all rules and
regulations promulgated thereunder, unless the context requires otherwise. The words “include,” “includes”
and “including” will be deemed to be followed by “without limitation.” Pronouns in masculine, feminine and
neuter genders will be construed to include any other gender, and words in the singular form will be construed to include the plural
and vice versa, unless the context otherwise requires. The words “this Agreement,” “herein,”
 “hereof,” “hereby,” “hereunder” and words of similar import refer to this Agreement as a whole
and not to any particular subdivision unless expressly so limited. The parties hereto intend that each representation, warranty and
covenant contained herein will have independent significance. If any party hereto has breached any representation, warranty or
covenant contained herein in any respect, the fact that there exists another representation, warranty or covenant relating to the
same subject matter (regardless of the relative levels of specificity) which such party hereto has not breached will not detract
from or mitigate the fact that such party hereto is in breach of the first representation, warranty or covenant.

 

(p)            Waiver.
No waiver by any party hereto of any default, misrepresentation or breach of warranty or covenant hereunder, whether intentional or not,
may be deemed to extend to any prior or subsequent default, misrepresentation or breach of warranty or covenant hereunder or affect in
any way any rights arising because of any prior or subsequent occurrence.

 

(q)            Specific
Performance. Each party hereto agrees that irreparable damage may occur in the event any provision of this Agreement was not performed
by the other party hereto in accordance with the terms hereof and that the such party shall be entitled to specific performance of the
terms hereof, in addition to any other remedy at law or equity.

 

(r)            No
Third-Party Beneficiaries. This Agreement is for the sole benefit of the parties hereto (and their respective successors and permitted
assigns) and nothing herein, express or implied, is intended to or shall confer upon any other person any legal or equitable right, benefit
or remedy of any nature whatsoever under or by reason of this Agreement.

 

(s)            Confidentiality.
Except as may be required by law, regulation or applicable stock exchange listing requirements (but subject in any case to the provisions
of Section ‎6(d) hereof), unless and until the transactions contemplated hereby and the terms hereof are publicly
announced or otherwise publicly disclosed by the Company, the parties hereto shall keep confidential and shall not publicly disclose the
existence or terms of this Agreement. Notwithstanding the foregoing, the Purchaser shall be permitted to disclose any information to its
affiliates and its and their respective directors, officers, employees, advisors, director or indirect owners, agents and representatives,
in each case so long as such person or entity has been advised of the confidentiality obligations hereunder; provided that the
Purchaser shall be liable for any breach of such confidentiality obligations by any such person or entity.

 

[Signature page follows]

 

    13

     

    

 

IN
WITNESS WHEREOF, the undersigned have executed this Agreement to be effective as of the date first set forth above.

 

	 	COMPANY:
	 	 
	 	USA ACQUISITION CORP.
	 	 
	 	By:  	 
	 	 	Name:
	 	 	Title:
	 	 
	 	SPONSOR:
	 	 
	 	USA SPONSOR ACQUISITION LLC
	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:
	 	 
	 	PURCHASER:
	 	 
	 	[APOLLO
    ENTITY]
	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:
	 	 
	 	Purchaser’s Address for Notices:
	 	 
	 	[APOLLO
    ENTITY]
	 	[Address]
	 	Attn: [●]
	 	Email: [●]
	 	with copies to:
	 	 
	 	Akin Gump Strauss Hauer & Feld LLP
	 	One Bryant Park
	 	New York, NY 10036
	 	Attn: Zachary Wittenberg
	 	Email: zwittenberg@akingump.com

 

[Signature page to Subscription
Agreement]

 

     

     

    

 

Schedule A1

 

Figures correspond to the minimum IPO size of 15,000,000 Public Units
as set forth in Section 1(a)(iii) of this Agreement.

 

	Subscribed Securities	 	Number of Subscribed Securities	 	 	Initial Purchase Price	 
	Private Placement Warrants*	 	 	402,500	 	 	$	402,500	 

 

		*	In the event that the number of shares of Class A Common
Stock issued in the IPO is increased for any reason (including, for the avoidance of doubt, because the Over-allotment Option is exercised),
the Purchaser agrees to purchase at the IPO Closing or Over-allotment Closing, as applicable, up to an additional $39,375 of Private
Placement Warrants in the aggregate at a price of $1.00 per warrant (or up to 39,375 Private Placement Warrants).

 

 

		1	Number of Subscribed Securities to be allocated among Subscribing
Parties.

 

    A-1

     

    

 

Schedule B1

 

Figures correspond to the minimum IPO size of 15,000,000 Public Units
as set forth in Section 1(a)(iii) of this Agreement.

 

	Additional Securities	 	Number of Additional Securities	 
	Founder Shares*	 	 	375,000	 
	Private Placement Warrants*	 	 	402,500	 

 

		*	In the event that the number of shares of Class A Common
Stock issued in the IPO is increased for any reason (including, for the avoidance of doubt, because the Over-allotment Option is exercised),
the Company agrees to issue to the Purchaser:

 

(i) at the
IPO Closing or Over-allotment Closing, as applicable, up to an additional 56,250 of Founder Shares for no consideration, such that the
total number of Founder Shares to be issued to the Purchaser remains equal to 10% of the total Founder Shares to be issued and outstanding;
and

 

(ii) at
the IPO Closing or Over-allotment Closing, as applicable, up to an additional 39,375 Private Placement Warrants for no consideration,
such that the total number of Private Placement Warrants to be issued to the Purchaser pursuant to Section 1(b) remains equal
to 5% of the total Private Placement Warrants to be issued and outstanding.

 

 

		1	Number of Additional Securities to be allocated among Subscribing
Parties.

 

    B-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}]]